The NHS Cancer Registry, which monitors the treatment history of cancer patients, has started testing a data integration system to improve the quality of records.
Two of the country’s eight regional cancer registries have started the trial, which uses tools from US-based InterSystems.
The Merseyside & Cheshire Cancer Registry and the Thames Cancer Registry will integrate, validate and manage information from hundreds of data sources for a rules-based system called Entente.
The NHS Cancer Registry plans to use Entente to assess outcomes of cancer treatments, study environmental and social factors when it comes to cancer risks, and evaluate cancer prevention and screening programmes.
Merseyside & Cheshire Cancer Registry and the Thames Cancer Registry are trialling InterSystems’ Ensemble tools. Ensemble includes an integration server, an application server, an object database and a unified development and management environment, which are all combined in a single packaged solution for integrating data.
The system will be used to take data feeds from multiple sources and link them automatically to the regional registries and the NHS centralised registry.
Currently, much of this work is done manually, meaning the quality of such work can be affected.
At the moment, it can take up to 18 months from the time a patient first starts cancer treatment for the data to reach the national database.